Psychedelics in Psychiatry: Where the Evidence Stands Today and What Comes Next

Research in psychedelic psychiatry continues to advance rapidly, expanding both scientific understanding and clinical interest. This session will provide a current, evidence-based update on psychedelic-assisted therapies, reviewing recent clinical trial data, evolving regulatory developments, and emerging therapeutic indications. Faculty will examine advances across established and novel compounds, discuss safety and implementation considerations, and address ongoing controversies surrounding access and use. Emphasis will be placed on distinguishing validated clinical evidence from public enthusiasm, helping psychiatrists understand where the field stands today and how psychedelic therapies may realistically integrate into future psychiatric practice.